Clinical imaging solutions that make a difference.
Clinical imaging solutions that make a difference.
Since 1997, Calyx has helped global biopharmaceutical companies and CROs successfully leverage medical imaging in their clinical trials. We offer a full range of imaging services and deliver therapeutically aligned value that allows you to best assess the safety, efficacy, and effectiveness of your compounds, time after time.
Whether you’re in early phase development looking to partner, planning to take your compound through regulatory approval, or even seeking breakthrough therapy designation / approval, lean on Calyx’s 25+ years’ experience and benefit from a tailored core imaging strategy proven to meet your clinical development objectives.
Since 1997, Calyx has helped global biopharmaceutical companies and CROs successfully leverage medical imaging in their clinical trials. We offer a full range of imaging services and deliver therapeutically aligned value that allows you to best assess the safety, efficacy, and effectiveness of your compounds, time after time.
Whether you’re in early phase development looking to partner, planning to take your compound through regulatory approval, or even seeking breakthrough therapy designation / approval, lean on Calyx’s 25+ years’ experience and benefit from a tailored core imaging strategy proven to meet your clinical development objectives.
Successful clinical trial imaging requires the experience and insight of professionals who understand the complexities of your clinical trial design, the nuances of the disease state you’re studying, and the regulations in place to meet your goals.
Calyx’s 80+ imaging experts each have a career’s worth of experience merging the clinical, academic, and commercial interests of medical imaging research and are responsible for hundreds of publications and patents in the imaging space, including criteria publications, biomarker development, and imaging processes.
Get to know the people that make the Calyx Medical Imaging difference
Successful clinical trial imaging requires the experience and insight of professionals who understand the complexities of your clinical trial design, the nuances of the disease state you’re studying, and the regulations in place to meet your goals.
Calyx’s 80+ imaging experts each have a career’s worth of experience merging the clinical, academic, and commercial interests of medical imaging research and are responsible for hundreds of publications and patents in the imaging space, including criteria publications, biomarker development, and imaging processes.
Get to know the people that make the Calyx Medical Imaging difference
Calyx’s team of Scientific Experts help set up your clinical trial imaging effectively and efficiently from the start, providing consultation on trial design, protocol review, imaging charter development, clinical data management, EDC design, and site/investigator training.
Our professional medical writing team is pivotal to the successful clinical trials repeatedly delivered by Calyx Medical Imaging. The team of 13 professional medical writers leverage significant experience (some having worked with Calyx for over two decades) to develop effective imaging charters that serve as the de facto guide for clinical trial imaging management and review. Rely on their experience, which spans over 600 clinical trials, across nearly 200 indications, and using over 100 different imaging criteria.
Our flexibility in choosing readers enables you to utilize virtually any KOL as an expert reader. Calyx’s reviewer network includes over 1,100 board certified readers, made up of industry leaders, criteria authors, and radiology department chairs from world class hospitals. All active practitioners located throughout North America, Europe, China and India, Calyx reviewers undergo rigorous training and testing to deliver high quality analysis data based on independent and unbiased image evaluations.
Calyx’s front-line teams deliver the highest level of support without juggling too many studies. Our professional project managers oversee an average of only six Medical Imaging studies at a time, ensuring you study gets the attention it deserves, whether you’re a leading pharma company, a small biotech, or anywhere in between.
Calyx has significant experience managing the imaging components of clinical studies – across all therapeutic areas, with varying degrees of complexity, and in all phases of clinical development. Regardless of study phase, Calyx Medical Imaging experts will guide you through the highly nuanced world of clinical trial imaging to ensure your development program succeeds. Or if it’s going to fail, to fail fast.
With experience from 2,600+ imaging studies and having supported over 250 new drug approvals – including half of the recently approved oncology treatments designated as breakthrough therapies – Calyx Scientific Consultants can help you design and implement an imaging strategy that gets your compound across the finish line. Faster.
With experience from 2,600+ imaging studies and having supported over 250 new drug approvals – including half of the recently approved oncology treatments designated as breakthrough therapies – Calyx Scientific Consultants can help you design and implement an imaging strategy that gets your compound across the finish line. Faster.
A very big thank you to Calyx Medical Imaging who worked outside of their turnaround timelines to review the scans that ultimately allowed the central team to approve enrollment to facilitate treatment of this patient as quickly as possible. This is a true testament of our values in ensuring that we get treatment as quickly as possible to patients that are in need.
We are so absolutely impressed with the Calyx Medical Imaging team…who has been fabulous to collaborate with. We appreciate the team working on tight timelines to help us meet our study start initiation goals and look forward to continuing our partnership!
We would like to thank the Calyx Medical Imaging team very much for your contribution to this wonderful (oncology) study outcome. Without you, this (marketing authorization) would have never been possible.
We relied heavily on Calyx’s IRT expertise and followed their recommendations for overcoming our studies’ challenges, resulting in a solution that perfectly met our RTSM needs for two complex gout trials.
We’re pleased to partner with Calyx and are confident that our customers will benefit from the scientific, medical, and clinical expertise they have honed during their 30 years of delivering reliable eClinical solutions to the clinical development industry.
We chose to partner with Calyx due to their tenured scientific, medical, and technical teams who possess a depth and diversity of experience in providing reliable data outcomes.
Calyx has deep technical expertise in various tumor response criteria, imaging modalities, image collection logistics, data management and regulatory requirements. They gave ArriVent invaluable advice during protocol and charter development. This is coupled with a team of world-class highly specialized independent radiologists, imaging scientists, project managers, medical writers, a very efficient budget and contract group as well as superb internal processes and systems all of which contributed to a very smooth program kick-off for our lead molecule.
A big thank you to the Calyx Medical Imaging team. This (approval) is also your accomplishment, and you should be very proud of the work you have done to make this possible. More approvals to come!
To: Calyx
From: Top 5 Pharmaceutical Company
Subject: Calyx Medical Imaging helps get patients treated quickly
A very big thank you to Calyx Medical Imaging who worked outside of their turnaround timelines to review the scans that ultimately allowed the central team to approve enrollment to facilitate treatment of this patient as quickly as possible. This is a true testament of our values in ensuring that we get treatment as quickly as possible to patients that are in need.
To: Calyx
From: Top 5 Pharmaceutical Company
Subject: IRT team are great collaborators
I’m very happy with the collaboration we have seen with Calyx’s IRT team, their open communication, and their ability to discuss and solve issues.
To: Calyx
From: Top 5 Pharmaceutical Company
Subject: Calyx Medical Imaging Made this Approval Possible
A big thank you to the Calyx Medical Imaging team. This (approval) is also your accomplishment, and you should be very proud of the work you have done to make this possible. More approvals to come!
– Global Trial Manager
Liver Cancer Development Program
TO: Calyx
FROM: Veralox
SUBJECT: Calyx Medical Imaging – Thank you for meeting tight timelines
I am very impressed with the Calyx Medical Imaging team who have been incredible collaborators in helping us to advance our lead program. We especially appreciate the team working on tight timelines to help us meet our study start initiation goals. Given that we are a small company, we rely on our collaborators, and the team at Calyx works seamlessly beside us to help us advance our development programs. I look forward to continuing our partnership!
– Alicia Herr, PMP,
Veralox Therapeutics
To: Calyx
From: Top 5 Pharmaceutical Company
Subject: Calyx Medical Imaging – Transparent, Constant Collaboration
We worked very closely with Calyx on the pivotal uterine fibroid studies. Critical components of success included transparent constant collaboration with real-time communication at all levels between our study team and Calyx. This kind of communication throughout the life of the study helped to ensure our team had the information needed to make timely informed decisions and to deliver quality data for our deliverables. We were able to establish lessons learned from prior studies and implement those on this study. I’m looking forward to continuing our work together as we strive to bring more treatment options to women.
To: Calyx
From: Arrivent
Subject: Global Oncology Program – Calyx Medical Imaging Head and Shoulders above the Rest
I am writing to give testimony to the expert independent central imaging review services provided by Calyx in support of two of ArriVent’s global clinical oncology studies. Calyx has deep technical expertise in various tumor response criteria, imaging modalities, image collection logistics, data management and regulatory requirements. They gave ArriVent invaluable advice during protocol and charter development. This is coupled with a team of world-class highly specialized independent radiologists, imaging scientists, project managers, medical writers, a very efficient budget and contract group as well as superb internal processes and systems all of which contributed to a very smooth program kick-off for our lead molecule.
We have interviewed a number of different imaging CROs and Calyx is definitely head and shoulder above the others.
– Morgan Lam
SVP, Development Operations & Business Management,
Arrivent Biopharma
To: Calyx
From: Top 3 Pharmaceutical Company
Subject: Thank you Calyx Medical Imaging – Osteoporosis Trial Success
I would like to thank the Calyx Team very much for your contribution to this wonderful study outcome. Without you this marketing authorization would have never been possible.
-Medical Lead, Osteoporotic Trial,
Top 3 Pharmaceutical Company
To: Calyx
From: ProTrials
Subject: Pleased to partner with Calyx
We’re pleased to partner with Calyx and are confident that our customers will benefit from the scientific, medical, and clinical expertise they have honed during their 30 years of delivering reliable eClinical solutions to the clinical development industry.
– Christy Meyer
Director, Quality Insurance,
To: Calyx
From: LG Chem
Subject: Calyx IRT – Simplifying Complicated Randomization
I sincerely appreciate your cooperation and Calyx’s team effort for our program.
We could not have successfully completed the IRT development for both Ph3 studies without Calyx’s team expertise.
As you know, our Ph3 studies are very complex and your high degree of experience, knowledge and system (platform) were required in order to develop the IRT we wanted. Also, there were some challenges and concerns due to protocol amendment by LGC during IRT development.
But, we relied heavily on Calyx’s expertise in IRT to deliver these two complex trials in our Gout program. Calyx made recommendations on how to overcome some of the challenged we were facing, and it resulted in a solution that perfectly meets our needs.
I have been working for 13 years in clinical development area in pharmaceutical industry. Even if my experience was relatively short, I can tell that Calyx’s platform is very valid and elaborate compared to other IRT systems.
Thank you so much.
– Younghwan Jang,
Study Lead,
LG Chem, Ltd.
To: Calyx
From: ClinChoice
Subject: Partnering with Calyx for reliable data outcomes
We chose to partner with Calyx due to their tenured scientific, medical, and technical teams who possess a depth and diversity of experience in providing reliable data outcomes.
– Tiepu Liu, President,
Global Biometrics,
ClinChoice
